Global Transfection Technologies Market 2018-2022 | Rising Demand for Monoclonal Antibodies to Boost Demand | Technavio
Jul. 31, 2018
LONDON--(BUSINESS WIRE)--Jul 31, 2018-- analysts forecast the global transfection technologies market to grow at a CAGR of almost 9% during the forecast period, according to their latest market research report.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180731006001/en/
Technavio has published a new market research report on the global transfection technologies market from 2018-2022. (Graphic: Business Wire)
The increased use of dual-reporter essays and co-transfection experiments is one of the major trends being witnessed in the . With the rise in biological and pharmaceutical research, there has been a rise in the use of dual-reporter systems due to their advantages over single reporter systems. A dual reporter system allows expression to be normalized for cell number and transfection efficiency. With the use of dual reporter system, it is easy to determine if the effects are due to the treatment of cells or a response from experimental reporter.
According to Technavio analysts, one of the key factors contributing to the growth of the global transfection technologies market is the rising demand for monoclonal antibodies:
Global transfection technologies market: Rising demand for monoclonal antibodies
Monoclonal antibodies are identical immune cells and one of the products in the pharmaceutical industry that is witnessing huge demands. They have an array of applications in the field of biology, diagnostic imaging, medicine, and biochemistry. Some of the medical application areas include sclerosis, cancer, rheumatoid arthritis, cardiovascular diseases, psoriasis, Crohn’s disease, and ulcerative colitis.
According to a senior analyst at Technavio for research on life science research tools, “Increase in demand for monoclonal antibodies triggers the need for developing new technologies for production. With the growing prevalence of chronic diseases, among other ailments, there is a high demand for antibiotic treatment.”
Global transfection technologies market: Segmentation analysis
The global transfection technologies market research report provides market segmentation by end-user (pharmaceutical and biotechnology companies, CROs, and academic and research institutes) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
Of the two major end-users, the pharmaceutical and biotechnology companies segment held the largest market share in 2017, contributing to over 44% of the market. This application segment will dominate the global market throughout the forecast period.
The Americas held the largest share of the market in 2017, accounting for close to 46% share. It was followed by EMEA and APAC respectively. North America is a major revenue contributor in the Americas. The growth in the region can be attributed to the rapidly increasing infectious diseases demanding the need of antibiotics and other drugs.
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market LandscapeMarket ecosystem Market characteristics Market segmentation analysis
Market SizingMarket sizing Market size and forecast
Five Forces Analysis
Geographical SegmentationRegional comparison Key leading countries
Vendor LandscapeVendors covered Vendor classification Market positioning of vendors Competitive scenario
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20180731006001/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: HEALTH GENETICS
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 07/31/2018 05:50 PM/DISC: 07/31/2018 05:51 PM